Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q1 2026

Phibro Animal Health Q1 2026 Results: Net Income $29.5M, Up 11.3% YoY

Phibro Animal Health Corp reported net sales of $386.8 million for the quarter ended September 30, 2026, a 6% increase compared to the prior year. Net income rose to $29.5 million ($0.72 per diluted share) from $26.5 million, driven by higher sales volume and improved foreign currency impacts despite an increase in selling, general, and administrative expenses.

Watch the Phibro Animal Health Corp earnings callFull call on the ALFA USA YouTube channel
Q1 2026 at a glance · $ million
MetricQ1 2026Q1 2025
Revenue386.8363.9
Gross profit128.5119.8
Profit before tax38.836.3
Net income29.526.5
EPS (diluted, $ a share)$0.72$0.65

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+11.3%
Revenue, year on year+6.3%
Gross margin33.2%
Operating margin12.8%
Source

10-Q filed with the SEC, NASDAQ: PAHC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Phibro Animal Health Corp: key numbers

Share price
$35.02Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Phibro Animal Health Corp

All →
4:33 PM ET 8-K
Financial Results

Phibro Animal Health Financial Results

Phibro Animal Health reported Q1 2027 net sales of $386.8 million, a 6% increase year-over-year, driven by growth in Mineral Nutrition and Performance Products. The company maintained its full-year fiscal 2027 guidance despite regulatory headwinds for virginiamycin in Brazil. Additionally, shareholders ratified the election of three Class I directors and the appointment of PwC as auditors at the annual meeting.

Term
Q1 2027

“First quarter results exceeded our expectations and grew on top of a strong first quarter last year. The outperformance was led largely by a strong start to the year in Mineral Nutrition and Performance Products while our core Animal Health business delivered sales in line with our plan and Adjusted EBITDA ahead of plan, including the benefit of certain costs that shifted into the second quarter.”

Dani Bendheim, President and Chief Executive Officer

“Improving working capital and cash conversion is a top priority, and we are committed to delivering meaningful progress during fiscal 2027.”

Dani Bendheim, President and Chief Executive Officer
4:16 PM ET 8-K
Dividend

Phibro Animal Health Dividend

Phibro Animal Health Corporation declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. The dividend is payable on December 16, 2026, to stockholders of record as of November 25, 2026.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.